The Ampa Receptor as a Therapeutic Target: Current Perspectives and Emerging Possibilities

Citations Over Time

Abstract

The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a subtype of the ionotropic glutamate receptors that plays a prominent role in neurotransmission and is widespread throughout the CNS. Because of this, its malfunction can result in a multitude of nervous system diseases. This review looks at compounds that are able to modulate AMPAR function by binding to one of several sites on the receptor that either downregulate its function (competitive, noncompetitive and uncompetitive antagonists) or upregulate its function (positive modulators). It will also give an account of the various diseases that have implicated AMPAR dysfunction and how specific types of AMPAR modulator may be beneficial in their treatment. The AMPAR remains an unexploited but important therapeutic target.

Related Papers

• → Auxiliary Subunits Assist AMPA-Type Glutamate Receptors(2006)381 cited
• → A Photochromic Agonist of AMPA Receptors(2012)85 cited
• → The Ampa Receptor as a Therapeutic Target: Current Perspectives and Emerging Possibilities(2010)18 cited
• → Controlling Ca2+Permeable α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Photochromic Ion Channel Blockers(2018)13 cited
• → Glutamate receptor ionotropic AMPA (GRIA; GLUR; AMPAR)(2009)